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Is grayanotoxin directly responsible for mad honey
poisoning-associated seizures
Abdülkadir GÜNDÜZ1, Murat AYDIN1, Metehan AKÇA2,4, Süha TÜRKMEN1,
Süleyman TÜREDİ1, Umut ERYİĞİT1, Ali CANSU3,4, Mehmet YILDIRIM2,4

Aim: The aim of this study was to investigate the effects of grayanotoxin on epileptiform activity in rats.
Materials and methods: Forty-two male Sprague Dawley rats were equally divided into 1 of 7 groups. Thirty minutes
after induction of epileptiform activity induced by penicillin injection, 0.5, 1, 2, 4, or 8 μg of grayanotoxin-III was
intracerebroventricularly administered. Epileptiform activity spike frequency and amplitude were converted into
numerical data using software following the experiment.
Results: Our results show that grayanotoxin reduces epileptiform spike frequency and amplitude in a dose-dependent
manner. Five minutes postinjection, grayanotoxin significantly reduced epileptiform activity, especially at higher doses.
This acute effect subsequently declined, but a dose-dependent decrease was observed through the end of the experiment.
This suggests that the first observed effect of grayanotoxin on spikes probably consists of blocking voltage-gated sodium
channel inactivation.
Conclusion: Grayanotoxin’s suppression of epileptiform activity in this experimental study indicates that grayanotoxin
is not directly responsible for mad honey poisoning-associated seizures observed in a clinical context.
Key words: Grayanotoxin, mad honey, seizure, experimental epilepsy, ECoG, rat

Introduction
Grayanotoxin is found in the leaves and flowers of
rhododendrons, of which there are more than 850
varieties in the world, that grow in wet forests along
Turkey’s Black Sea coast (1,2). Since toxins taken
up from rhododendron flowers by bees are not
detoxified in their organisms, they cause poisoning by
becoming directly mixed in with honey (mad honey
poisoning) (3). Grayanotoxins exhibit toxic effects by
binding to sodium channels in cell membranes. They
increase the permeability of sodium ions in excited
membranes. Experimental studies have shown that
the toxin affects the skeletal muscles, heart muscle,

respiratory system, central nervous system, and
endocrine system (4,5).
Patients exposed to grayanotoxins generally
exhibit mild symptoms such as nausea-vomiting
and enhanced secretion or paresthesia, although
potentially lethal findings such as full atrioventricular
block or respiratory depression may also emerge
(6). Grayanotoxin may also, albeit rarely, cause
convulsions (7). Are seizures a direct effect of
grayanotoxin on neuronal excitability or rather
a result of hypotension-associated hypoxia? The
literature contains no clinical or experimental studies
capable of shedding light on this clinical problem and
answering the questions arising from it.
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This experimental study was intended to
investigate the effect of ‘mad honey’ on epileptiform
activity induced in rats with penicillin and to
determine whether or not grayanotoxin, the toxic
agent of mad honey, is directly responsible for
epileptic seizures.
Material and methods
Animals
Experiments were performed on 42 adult male
Sprague Dawley rats weighing 240-280 g. Adult male
rats were obtained from the Karadeniz Technical
University Research Center. Animals were housed
under a 12:12 light-dark cycle (light on at 0700
hours) and at a room temperature of 20 ± 2 °C. They
were given free access to food and water. Every effort
was made to minimize animal suffering and the
number of animals used. Experimental procedures
were approved by the Animal Experimentation
Ethics Committee of Karadeniz Technical University.
All experiments were carried out according to local
guidelines for the care and use of laboratory animals
and the guidelines of the European Community
Council for experimental animal care.
Drug and drug administration
Grayanotoxin-III, ethanol, and urethane were
purchased from Sigma (St. Louis, MO, USA).
Grayanotoxin-III was dissolved in ethanol to which
was added sterile saline solution (final solution
ethanol/saline, 2:98 v/v, respectively), and given
in doses of 0.5, 1, 2, 4, or 8 μg/rat (2 μL) via the
intracerebroventricular (i.c.v.) route 30 min after
penicillin administration. The control and ethanol
groups were injected via the i.c.v. route with 0.9%
saline and 2% ethanol, respectively, 30 min after
penicillin injection in a volume of 2 μL; injections
were administered into the left lateral ventricle of each
rat through a stereotaxic apparatus, 0.8 mm posterior
to the bregma, 1.5 mm lateral to the midline, and 3.6
mm ventral to the surface of the cortex, based on the
atlas of the rat brain (8).
Experimental design
Forty-two animals were equally divided into 7
experimental groups: 1) 500 units of penicillin (2.5
μL, intracortical (i.c.)) + 0.9% NaCl (2 μL, i.c.v.); 2)

500 units of penicillin (2.5 μL, i.c.) + 2% ethanol (2
μL, i.c.v.); 3) 500 units of penicillin (2.5 μL, i.c.) + 0.5
μg of grayanotoxin-III (2 μL, i.c.v.); 4) 500 units of
penicillin (2.5 μL, i.c.) + 1 μg of grayanotoxin-III (2
μL, i.c.v.); 5) 500 units of penicillin (2.5 μL, i.c.) + 2
μg of grayanotoxin-III (2 μL, i.c.v.); 6) 500 units of
penicillin (2.5 μL, i.c.) + 4 μg of grayanotoxin-III (2
μL, i.c.v.), and 7) 500 units of penicillin (2.5 μL, i.c.)
+ 8 μg of grayanotoxin-III (2 μL, i.c.v.). The 6 rats in
each group were then further divided into 3 groups
of 2 animals each.
Surgical procedure
The animals were anesthetized with an intraperitoneal
(i.p.) injection of urethane (1.25 g/kg), additional
doses being given as needed (9). The left cerebral
cortex was carefully exposed by craniotomy.
After incision of the skull, the head was placed
in a stereotaxic apparatus. Body temperature was
monitored using a rectal probe and maintained at 37
°C with a homeothermic blanket system (Harvard
Homoeothermic Blanket, Harvard Instruments,
South Natick, MA, USA).
Induction of epileptiform activity
Epileptiform activity was induced by i.c. injection
of penicillin G potassium (500 units/2.5 μL) using a
Hamilton microsyringe (Type 701N, Hamilton Co.,
Reno, NV, USA) after recording baseline activities
within 10 min.
Electrophysiological recordings
Two Ag-AgCl ball electrodes were placed over the
left somatomotor cortex (electrode coordinates: first
electrode, 2 mm lateral to the sagittal suture and 2
mm anterior to the bregma; second electrode, 2 mm
lateral to the sagittal suture and 5 mm posterior to the
bregma). The common reference electrode was fixed
on the right pinna. Recordings of electrocorticogram
(ECoG) activity were carried out using a 16-channel
data acquisition system (PowerLab 16/30, AD
Instruments, Castle Hill, Australia). All recordings
were made with animals under anesthesia. The signals
from the electrodes were amplified and filtered (0.150 Hz bandpass) using BioAmp amplifiers (AD
Instruments). The ECoG signal was then digitized
at a sampling rate of 1024. The digitized brain signal
was displayed and stored on a personal computer.
The frequency and amplitude of epileptiform ECoG
activity was analyzed offline (10).
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Statistical analysis

Results

Spike frequencies and amplitudes for each animal
were automatically calculated and measured
using LabChart Pro v7.1 (PowerLab software,
AD Instruments). The results are given as means
± standard error of the mean (SEM). Statistical
comparisons were performed using SPSS 16.0
(SPSS Inc., Chicago, IL, USA). Data analysis was
performed using ANOVA and Tukey post hoc tests
for comparisons. Data are expressed as mean ± SEM.
Statistical significance was set at P < 0.05.

Baseline activities of each animal were recorded
before the administration of penicillin, having
confirmed that none of the animals had spontaneous
epilepsy (Figure 1). I.c. injection of penicillin (500
units) induced epileptiform activity within 3-5 min
after administration (Figure 1). It reached a constant
level in terms of frequency and amplitude in 30 min,
and this lasted for 4-5 h.
Forty-five minutes after i.c.v. injection of saline
solution, the mean spike frequency and amplitude

500 μV
5 sec
A) Baseline activity

E) 1 μg Grayanotoxin-III

1000 μV
30 sec
B) Control (500 IU pencillin)

F) 2 μg Grayanotoxin-III

C) 2% Ethanol

G) 4 μg Grayanotoxin-III

D) 0.5 μg Grayanotoxin-III

H) 8 μg Grayanotoxin-III

Figure 1. Representative ECoGs at 42-48 min after injections: A) baseline ECoG
activity before the injection of penicillin or other substances; B) i.c. injection
of penicillin (500 IU) induced epileptiform activity at ECoG, while 0.9%
NaCl did not alter the frequency of penicillin-induced epileptic activity; C)
2% ethanol (i.c.v.) did not affect either the mean frequency or amplitude of
penicillin-induced epileptiform activity; D) 0.5 μg of grayanotoxin-III (i.c.v.)
did not affect either the mean frequency or amplitude of penicillin-induced
epileptiform activity; E) 1 μg of grayanotoxin-III (i.c.v.) did not alter either
the mean frequency or amplitude of penicillin-induced epileptiform activity;
F) at 2 μg, grayanotoxin-III (i.c.v.) significantly reduced both the mean of
frequency and the amplitude of epileptiform activity; G) at 4 μg, grayanotoxinIII significantly reduced both the mean frequency and amplitude of
epileptiform activity; H) 8 μg of grayanotoxin-III (i.c.v.) significantly reduced
both the mean frequency and amplitude of epileptiform activity.
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Spike/min

were 32.4 ± 6 spikes/min and 1427 ± 323 μV,
respectively. Control group epileptiform activity
spike frequency and amplitude after the injection of
0.9% NaCl exhibited no great increase or decrease
up to the end of the study, at 26-32 spikes/min and
1300-1500 μV, respectively (Figures 2 and 3). In
the group administered ethanol (2%, i.c.v.), the
mean spike frequency and amplitude 45 min after
the injections were 31.5 ± 3 spikes/min and 1392
± 320 μV. Compared with the control group, the
injection of 2% ethanol had no statistically significant
effect on epileptiform activity spike frequency or
amplitude (Figures 2 and 3). Thirty minutes after the
i.c. injection of penicillin, 0.5 μg of grayanotoxinIII was administered i.c.v. Forty-five minutes after
the administration of 0.5 μg of grayanotoxin-III,

45

epileptiform activity spike frequency and amplitude
were 19.8 ± 2 spikes/min and 1199 ± 221 μV,
respectively. There was a slight reduction in mean
spike frequency and amplitude after application of
a 0.5 μg dose of grayanotoxin-III, but the difference
was not statistically significant (Figures 2 and 3).
Forty-five minutes after the i.c.v. administration of
1 μg of grayanotoxin-III, epileptiform activity mean
spike frequency and amplitude were 21.6 ± 1 spikes/
min and 996 ± 181 μV. There was again a slight
decrease in mean spike frequency and amplitude
in the group administered 1 μg of grayanotoxin-III,
but this was also not statistically significant (Figures
2 and 3). Forty-five minutes after i.c.v. injection of 2
μg of grayanotoxin-III, epileptiform activity mean
spike frequency and amplitude were 20.1 ± 4 spikes/
Control
0.5 μ g GTX - III
2 μ g GTX -III
8 μ g GTX -III

The effects of grayanotoxin - III doses on the spike frequency

2% Ethanol
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4μ g GTX -III
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Figure 2. The effects of i.c.v. administration of grayanotoxin-III on the mean spike frequency of penicillin-induced epileptiform
activity. At 0.5 and 1 μg/rat (i.c.v.), grayanotoxin-III did not affect the mean frequency of epileptiform activity. At 2, 4,
and 8 μg/rat (i.c.v.), it significantly reduced the mean frequency of epileptiform activity (triangle, P < 0.05; 4-pointed
star, P < 0.01; 5-pointed star, P < 0.001).
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Figure 3. The effects of i.c.v. administration of grayanotoxin-III on the mean spike amplitude of penicillin-induced epileptiform
activity. At 0.5 and 1 μg/rat, grayanotoxin-III (i.c.v.) did not affect the mean amplitude of epileptiform activity. At 2, 4,
and 8 μg/rat (i.c.v.), it significantly reduced the mean amplitude of epileptiform activity (triangle, P < 0.05; 4-pointed
star, P < 0.01; 5-pointed star, P < 0.001).

min and 780 ± 265 μV. Epileptiform activity spike
frequency and amplitude decreased 5 min after
the injection of 2 μg of grayanotoxin-III, but this
effect was short-lived (P < 0.05). Toward the end
of the experiment, average spike frequency in the
group administered 2 μg of grayanotoxin-III again
decreased significantly after 75 min (P < 0.05; Figures
2 and 3). Forty-five minutes after i.c.v. administration
of 4 μg of grayanotoxin-III, epileptiform activity
mean spike frequency and amplitude were 12.5 ± 3
spikes/min and 718 ± 282 μV. Epileptiform activity
again temporarily decreased in terms of both spike
and amplitude 5 min after injection of a 4 μg dose
of grayanotoxin-III (P < 0.05). Mean spike frequency
later decreased significantly as of 35 min, and mean
spike amplitude decreased significantly as of 65
min (P < 0.05 and P < 0.01; Figures 2 and 3). Forty1090

five minutes after i.c.v. administration of 8 μg of
grayanotoxin-III, epileptiform activity mean spike
frequency and amplitude were 8 ± 2 spikes/min and
103 ± 36 μV. Five minutes after injection of an 8 μg
dose, mean spike frequency declined significantly
(P < 0.05), and this persisted as of 25 min until
the end of the experiment (P < 0.001; Figure 2).
Statistical analysis of mean spike amplitude revealed
significance at the P < 0.05 level between 5 min and
25 min postinjection, at the P < 0.01 level between 30
and 50 min, and at the P < 0.001 level between 55 and
90 min (Figure 3). At the end of the experiment all
of the animals in the 0.9% NaCl, 2% ethanol, 0.5 μg
grayanotoxin-III, and 1 μg grayanotoxin-III groups
survived. Two rats in the 2 μg grayanotoxin-III group,
3 rats in the 4 μg grayanotoxin-III group, and 4 rats in
the 8 μg grayanotoxin-III group died (Figure 4).
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reduces penicillin-induced epileptiform discharges
by affecting GABA receptors.

The survival rate of rats
1
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However, the effect of grayanotoxin, especially on
early stage epileptiform discharges, may be associated
with GABA discharges. There is therefore a need for
studies demonstrating the effect of grayanotoxin on
GABA receptors.
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Figure 4. The effects of i.c.v. administration of grayanotoxin-III
on rat survival rates.

Discussion
In this experimental epileptiform activity model, i.c.v.
administration of grayanotoxin caused a decrease in
epileptiform activity spike frequency and amplitudes.
Grayanotoxin was administered in dosages from
0.5 μg to 8 μg. As dosages increased, there was a
dose-correlated decrease in spike frequency and
epileptiform activity was suppressed.
Following the i.c. administration of penicillin,
there was a greater than 50% decrease in spike
frequencies at 5 min after the grayanotoxin-III
injections, especially in the 2, 4 and 8 μg toxin
groups. Immediately afterward, there was a rise in
spike frequencies, while from 25 min on there was
a highly significant decrease in spike frequency,
particularly in the 8 μg group (P < 0.001). The second
decrease in spike frequencies increased from 35 min
in the 4 μg group (P < 0.05) and acquired greater
significance as of 45 min (P < 0.01). The decrease
in spike frequencies becomes more significant as
the dose of toxin administered increases and the
time to appearance of dose-related decrease in spike
frequencies shortens. Penicillin is known to cause
epileptic activity by selectively blocking GABAassociated postsynaptic inhibition (11). Sitges
reported that grayanotoxin increases the secretion
of GABA, a powerful inhibitor neurotransmitter in
presynaptic membranes (12). We cannot say, on the
basis of our results in this study, that grayanotoxin

As with spike frequency, the same doses of
toxin administered to the same groups also led to a
significant decrease in spike amplitudes correlated
to the increase in grayanotoxin dosage. In contrast,
however, in the 8 μg group, spike amplitudes began
decreasing very severely and very early (P < 0.05 at
5 min, P < 0.01 at 30 min, and P < 0.001 at 55 min).
Spike amplitudes declining so fast and to such an
extent, especially in the application of high doses,
suggests that the toxin significantly suppresses
the neuronal activity that establishes epileptiform
activity. When the other groups were examined, the
level and speed of decrease in amplitudes was less
significant at lower dosages. Grayanotoxins are toxins
dissolved in fat that increase channel activity and
permeability of sodium ions in the cell membrane
by binding to voltage-gated sodium channels in
the membrane (13). In a study by Maejima et al. in
2003, grayanotoxin was reported to have a 3-stage
effect on voltage-gated sodium channels (14).
First, grayanotoxin binds to voltage-gated sodium
channels during their opening phase. Once binding
has taken place, the channel cannot be inactivated.
The channels are subsequently modified. Finally, the
modified sodium channels are hyperpolarized. This
leads to voltage-dependent activation or inactivation
in the cell membrane (14). The way that grayanotoxin
caused a dose-dependent significant decrease in
amplitude in epileptiform discharges by binding to
voltage-gated sodium channels suggests that it thus
blockades neuron excitability.
One of the factors that we considered in this study
was rat survival rates. In the control group, the ethanol
group and the 0.5 μg and 1 μg groups’ survival rates
were 100%, compared to 66.60% in the 2 μg group,
50.8% in the 4 μg group, and 33.3% in the 8 μg group.
In conclusion, mortality rose with dosage. A decrease
in rat respiratory rate was first observed, followed by
a deceleration in heart beat and finally cardiac arrest.
This finding shows that high doses in rats primarily
block the respiratory center.
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In light of the data from this study on significant
changes in spike amplitudes in an experimental
epilepsy model, the primary effect of grayanotoxin
on spikes probably comes about by blocking voltagegated sodium channel inactivation. However,
considering the way that grayanotoxin increases
GABA discharges, further studies illuminating the
effect of grayanotoxin on GABA are now needed.
With high doses it probably leads to respiratory
depression and death by reducing the excitability of
all cortical and subcortical neurons. This pioneering,

specific study is the first on the subject, and support
from further wider experimental and clinical studies
may reduce the number of deaths in poisoning with
grayanotoxin (mad honey poisoning).
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